Aditxt, Inc. (ADTX) vs Cadrenal Therapeutics, Inc. (CVKD)
Aditxt, Inc. and Cadrenal Therapeutics, Inc. are both Biotechnology companies. Aditxt, Inc. and Cadrenal Therapeutics, Inc. are of similar size ($4.4M and $4.3M). Cadrenal Therapeutics, Inc. has the higher net margin (0.00% vs −372,998.6%) and the lower return on invested capital (−427.5% vs 0.00%). Across the 12 metrics below, Aditxt, Inc. leads on 7 and Cadrenal Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | ADTX | CVKD | Biotechnology median |
|---|---|---|---|
| Gross margin | 20.28% | 0.00% | 65.16% |
| Operating margin | (128,143.36%) | 0.00% | 0.00% |
| Net margin | (372,998.60%) | 0.00% | 0.00% |
| Free cash flow margin | (129,979.72%) | 0.00% | 0.00% |
| Return on equity | 549.59% | (275.16%) | (57.72%) |
| Return on assets | (236.38%) | (199.59%) | (49.22%) |
| Return on invested capital | 0.00% | (427.54%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack